Clinical Trial Update: A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the long-term safety of astegolimab in adults with Chronic Obstructive Pulmonary Disease, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Astegolimab (astegolimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: RECRUITING